natgillin/translations-raw huggingface dataset:
It is important that you take Ibandronic acid Sandoz at the right time and in the right way.
Pomembno je, da jemljete zdravilo Ibandronska kislina Sandoz ob pravem času in na pravi način, saj lahko povzroči draženje, vnetje ali razjede požiralnika/grla (ezofagusa).
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 50 mg of ibandronic acid (as ibandronate sodium monohydrate).
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN Ena filmsko obložena tableta vsebuje 50 mg ibandronske kisline (v obliki natrijevega ibandronata monohidrata).
Hypocalcaemia**
Presnovne in prehranske motnje hipokalciemija**
Renal impairment
Draženje prebavil
This is because NSAIDs and Ibandronic acid Sandoz can both irritate your stomach and gut a type of antibiotic injection called “aminoglycoside” such as gentamicin.
To je zato, ker lahko oboji, NSAID in zdravilo Ibandronska kislina Sandoz dražijo želodec in črevesje.
Metabolism and nutrition disorders
Bolniki z motnjami kosti in presnove mineralov
Talk to your doctor or pharmacist before taking Ibandronic acid Sandoz • if you are allergic to any other bisphosphonates
Pred začetkom jemanja zdravila Ibandronska kislina Sandoz se posvetujte z zdravnikom ali farmacevtom
Physicians should be alert to any signs or symptoms signaling a possible oesophageal reaction and patients should be instructed to discontinue Ibandronic acid Sandoz and seek medical attention if they develop dysphagia, odynophagia, retrosternal pain or new or worsening heartburn.
Če se pri bolnikih med zdravljenjem z zdravilom Ibandronska kislina Sandoz pojavijo disfagija, bolečina pri požiranju, retrosternalna bolečina ali pojav ali poslabšanje zgage, morajo zdravljenje z zdravilom Ibandronska kislina Sandoz prekiniti in poiskati zdravniško pomoč.
Do not pass it on to others.
Ne izzovite bruhanja.
- Abnormalities of the oesophagus which delay oesophageal emptying such as stricture or achalasia - Inability to stand or sit upright for at least 60 minutes - Hypocalcaemia - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Ne jemljite zdravila Ibandronska kislina Sandoz če ste alergični na ibandronsko kislino ali katero koli sestavino tega zdravila (navedeno v poglavju 6); če imate težave s požiralnikom/grlom (ezofagusom), kot so zoženje ali težave s požiranjem; če ne morete skupaj stati ali sedeti pokončno vsaj eno uro (60 minut); če imate ali ste kdaj imeli nizke koncentracije kalcija v krvi.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer Carton
PODATKI NA ZUNANJI OVOJNINI Škatla
Do not take a double dose to make up for a forgotten dose.
Če ste pozabili vzeti zdravilo Ibandronska kislina Sandoz Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
It does not matter whether you take it with or without food.
Ni pomembno, ali jo vzamete s hrano ali brez nje.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 25 June 2015
Datum prve odobritve: 25 junij 2015
Consequently, the frequency of these adverse events is qualified as “not known”.
Zato je pogostnost teh neželenih učinkov opredeljena kot »neznana«.
• withdrawal symptoms in newborn babies in case of exposure during pregnancy,
• odtegnitveni simptomi pri novorojenčkih v primeru izpostavljenosti zdravilu v času nosečnosti,
The treatment duration should be the minimum necessary for symptom control and must not exceed 12 weeks.
Zdravljenje naj traja najkrajši čas, ki je potreben za obvladanje simptomov in ne sme trajati dlje kot 12 tednov.
• Unusual movements (especially of the face or tongue) and reduced level of consciousness.
• nenavadne gibe (posebno v mišicah obraza ali jezika) in zmanjšano stopnjo zavesti.
Try to take Aripiprazole Zentiva at the same time each day.
Prizadevajte si vzeti zdravilo Aripiprazol Zentiva vsak dan ob istem času.
In addition, cases of stroke or “mini” stroke have been reported.
Poleg tega so poročali tudi o primerih možganske kapi ali "male" kapi.
Less than 1% of unchanged aripiprazole was excreted in the urine and approximately 18% was recovered unchanged in the faeces.
Manj kot 1 % aripiprazola se je nespremenjenega izločilo v urinu in približno 18 % ga je bilo mogoče nespremenjenega najti v blatu.
• inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
• nezmožnost upreti se impulzu, težnji ali skušnjavi po dejanjih, ki bi lahko škodila vam ali drugim, kot so:
Alternatively, disperse the tablet in water and drink the resulting suspension.
Druga možnost je, da tableto raztopite v vodi in popijete nastalo suspenzijo.
• difficulty sleeping,
• težave s spanjem,
Blood pressure-lowering medicines: Aripiprazole Zentiva may increase the effect of medicines used to lower the blood pressure.
Zdravila za zniževanje krvnega tlaka: zdravilo Aripiprazol Zentiva lahko okrepi učinek zdravil, ki se uporabljajo za zniževanje krvnega tlaka.
The absolute oral bioavailability of the tablet formulation is 87%.
Absolutna peroralna biološka uporabnost zdravila v tabletah je 87 %.
Aripiprazole Zentiva with food, drink and alcohol This medicine can be taken regardless of meals.
Zdravilo Aripiprazol Zentiva skupaj s hrano, pijačo in alkoholom To zdravilo lahko jemljete ne glede na obroke.
If you are an elderly patient suffering from dementia (loss of memory and other mental abilities), you or your carer/relative should tell your doctor if you have ever had a stroke or “mini” stroke.
Če ste starejša oseba in imate demenco (slabšanje spomina in drugih duševnih sposobnosti), morate vi ali vaš skrbnik/sorodnik zdravniku povedati, če ste kdaj imeli možgansko kap ali "malo" kap.
Even if you feel better, do not alter or discontinue the daily dose of Aripiprazole Zentiva without first consulting your doctor.
Tudi če se počutite bolje, ne spreminjajte dnevnega odmerka in ne nehajte jemati zdravila Aripiprazol Zentiva, ne da bi se prej posvetovali z zdravnikom.
• past experience with excessive gambling.
• ste kdaj imeli težave s pretiranim hazardiranjem.
If you miss a dose, take the missed dose as soon as you remember but do not take two doses in one day.
Če ste pozabili vzeti zdravilo Aripiprazol Zentiva Če ste pozabili vzeti odmerek, ga vzemite takoj, ko se spomnite, vendar ne vzemite dveh odmerkov na en dan.
Pharmacotherapeutic group: Psycholeptics, other antipsychotics, ATC code: N05AX12
Farmakoterapevtska skupina: psiholeptiki, drugi antipsihotiki, oznaka ATC: N05AX12
Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41% and AUC by about 51%, suggesting that charcoal may be effective in the treatment of overdose.
Aktivno oglje (50 g), uporabljeno eno uro po aripiprazolu, je zmanjšalo Cmax aripiprazola za približno 41 % in AUC za približno 51 %, kar kaže, da bi bilo oglje lahko učinkovito za zdravljenje prevelikega odmerjanja.
The highest nontumorigenic exposure in female rats was 7 times the human exposure at the recommended dose.
Največja netumorogena izpostavljenost samic podgan je bila 7krat večja od izpostavljenosti človeka pri priporočenem odmerku.
Aripiprazole Zentiva is effective in a dose range of 10 to 30 mg/day.
Zdravilo Aripiprazol Zentiva je učinkovito v razponu odmerkov od 10 do 30 mg/dan.
At therapeutic concentrations, aripiprazole and dehydro-aripiprazole are greater than 99% bound to serum proteins, binding primarily to albumin.
V terapevtskih koncentracijah je več kot 99 % aripiprazola in dehidroaripiprazola vezanega na beljakovine v serumu, predvsem na albumin.
Following a single oral dose of [14C]-labelled aripiprazole, approximately 27% of the administered radioactivity was recovered in the urine and approximately 60% in the faeces.
Po enem samem peroralnem odmerku aripiprazola, označenega s [14C], se je približno 27 % aplicirane radioaktivnosti pojavilo v urinu in približno 60 % v blatu.
The point estimate of the hazard ratio (HR) was 0.461 (95% confidence interval, 0.242 - 0.879) in the full population.
Ocenjena vrednost razmerja ogroženosti (RO) je bila 0,461 (95-% interval zaupanja, 0,242-0,879) pri celotni poulaciji.
The European Medicines Agency has deferred the obligation to submit the results of studies with the reference medicinal product containing aripiprazole in one or more subsets of the paediatric population in the treatment of schizophrenia and in the treatment of bipolar affective disorder (see section 4.2 for information on paediatric use).
Evropska agencija za zdravila je začasno odložila zahtevo za predložitev rezultatov študij z referenčnim zdravilom, ki vsebuje aripiprazol za eno ali več podskupin pediatrične populacije pri zdravljenju shizofrenije in bipolarne afektivne motnje (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
• thoughts of suicide, suicide attempt and suicide;
• povečanje telesne mase, • misli na samomor, poskus samomora in samomor,
In a sub-analysis of the adolescent patients between the ages of 15 to 17 years, representing 74% of the total enrolled population, maintenance of effect was observed over the 26-week open-label extension trial.
Pri analizi podskupine mladostnikov, starih od 15 do 17 let, ki je obsegala 74 % vseh vključenih bolnikov, se je učinek ohranil ves čas 26-tedenskega odprtega podaljšanega preskušanja.
Manufacturer S.C. Zentiva S.A.
Izdelovalec S.C. Zentiva S.A.
• Certain antibiotics used to treat tuberculosis (rifabutin, rifampicin)
• določene antibiotike, ki se uporabljajo za zdravljenje tuberkoloze (rifabutin, rifampicin).
The overall completion rate was significantly higher for patients on aripiprazole (43%) than for haloperidol (30%).
Celotni delež dokončanja je bil pri bolnikih, ki so dobivali aripiprazol, značilno večji (43 %) kot pri tistih, ki so dobivali haloperidol (30 %).
• blood clots in the veins, especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing (if you notice any of these symptoms, seek medical advice immediately),
• krvni strdki v venah, zlasti v venah nog (simptomi vključujejo oteklino, bolečino in rdečino noge), ki lahko potujejo po krvnih žilah v pljuča in povzročijo bolečino v prsih in težave z dihanjem (če opazite katerega od navedenih simptomov, takoj poiščite zdravniško pomoč),
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Druga zdravila in zdravilo Aripiprazol Zentiva Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, vključno z zdravili, ki ste jih dobili brez recepta.
In the same trials, cerebrovascular adverse reactions (e.g. stroke, transient ischaemic attack), including fatalities, were reported in patients (mean age: 84 years; range: 78 - 88 years).
V istih preskušanjih so poročali o cerebrovaskularnih neželenih učinkih (npr. možganski kapi, prehodnem ishemičnem napadu), vključno s smrtnimi primeri (povprečna starost bolnikov: 84 let, razpon: 78-88 let).
However, the estimation of the HR for the younger (13 - 14 years) group was not precise, reflecting the smaller number of subjects in that group (aripiprazole, n = 29; placebo, n = 12), and the confidence interval for this estimation (ranging from 0.151 to 1.628) did not allow conclusions to be drawn on the presence of a treatment effect.
Vendar pa ocena razmerja ogroženosti pri skupini mlajših mladostnikov (13-14 let) ni bila točna zaradi manjšega števila preskušancev v tej skupini (aripiprazol, n = 29; placebo, n = 12), interval zaupanja za to oceno (ki je od 0,151 do 1,628) pa ne omogoča zaključkov o prisotnosti učinka zdravljenja.
Aripiprazole Zentiva contains the active substance aripiprazole and belong to a group of medicines called antipsychotics.
Zdravilo Aripiprazol Zentiva vsebuje učinkovino aripiprazol in spada v skupino zdravil, imenovanih antipsihotiki.
The score line is not intended for breaking the tablet.
Zareza ni namenjena delitvi tablete.
• Rapid heartbeat, agitation/aggressiveness, problems with speech.
• hitro bitje srca, vznemirjenost/agresivnost, težave pri govoru;
14 tablets 28 tablets 49 tablets 56 tablets 98 tablets
14 tablet 28 tablet 49 tablet 56 tablet 98 tablet
All ADRs are listed by system organ class and frequency; very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).
pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
Taking Aripiprazole Zentiva with some medicines may mean the doctor will need to change your dose of Aripiprazole Zentiva or the other medicines.
Če jemljete zdravilo Aripiprazol Zentiva z nekaterimi drugimi zdravili, bo morda zdravnik moral spremeniti vaš odmerek zdravila Aripiprazol Zentiva ali drugih zdravil.
In a haloperidol-controlled trial, the proportion of responder patients maintaining response to medicinal product at 52-weeks was similar in both groups (aripiprazole 77% and haloperidol 73%).
V preskušanju, nadzorovanem s haloperidolom, je bil delež odzivnih bolnikov, pri katerih se je odziv na zdravilo ohranil po 52 tednih, v obeh skupinah podoben (aripiprazol 77 % in haloperidol 73 %).
Aripiprazole is well absorbed, with peak plasma concentrations occurring within 3 - 5 hours after dosing.
Aripiprazol se dobro absorbira in doseže največjo koncentracijo v plazmi v 3 do 5 urah po uporabi.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially “sodium free”.
To zdravilo vsebuje manj kot 1 mmol natrija (23 mg) na tableto, kar v bistvu pomeni ‘brez natrija' .
In subgroup analyses the point estimate of the HR was 0.495 for subjects 13 to 14 years of age compared to 0.454 for subjects 15 to 17 years of age.
Pri analizi podskupin je bila ocenjena vrednost RO pri preskušancih, starih od 13 do 14 let, 0,495 v primerjavi s preskušanci, starimi od 15 do 17 let, pri katerih je razmerje bilo 0,454.
If you have the impression that the effect of Aripiprazole Zentiva is too strong or too weak, talk to your doctor or pharmacist.
Če menite, da je učinek zdravila Aripiprazol Zentiva premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.
Bolniki z redko dedno intoleranco za galaktozo, popolnoma zmanjšano aktivnostjo laktaze ali malabsorpcijo glukoze/galaktoze ne smejo jemati tega zdravila.
Treatment should be initiated at 2 mg (using an appropriate aripiprazole containing medicinal product) for 2 days, titrated to 5 mg for 2 additional days to reach the recommended daily dose of 10 mg.
Zdravljenje je treba uvesti v odmerku 2 mg (z uporabo primernega zdravila, ki vsebuje aripiprazol), ki ga bolnik jemlje 2 dni, nato pa se odmerek poveča do odmerka 5 mg, ki ga bolnik jemlje še dodatna 2 dni.
After a 13 - 26 week stabilisation on aripiprazole (2 - 15 mg/day) patients with a stable response were either maintained on aripiprazole or substituted to placebo for further 16 weeks.
Po 13-26 tednih stabilizacije na aripiprazolu (2-15 mg/dan) so bolniki s stabilnim odzivom nadaljnjih 16 tednov bodisi ostali na aripiprazolu ali pa so prešli na placebo.
If you take more Aripiprazole Zentiva than you should If you realise you have taken more Aripiprazole Zentiva than your doctor has recommended (or if someone else has taken some of your Aripiprazole Zentiva), contact your doctor right away.
Če ste vzeli večji odmerek zdravila Aripiprazol Zentiva, kot bi smeli Če ugotovite, da ste vzeli več zdravila Aripiprazol Zentiva, kot vam je priporočil zdravnik (ali če je vaše zdravilo Aripiprazol Zentiva vzel kdo drug), se takoj posvetujte s svojim zdravnikom.
Irritability associated with autistic disorder
Razdražljivost, povezana z avtistično motnjo
In contrast the 95% confidence interval for the HR in the older subgroup (aripiprazole, n = 69; placebo, n = 36) was 0.242 to 0.879 and hence a treatment effect could be concluded in the older patients.
V nasprotju s tem je bil 95-% interval zapanja za RO pri starejši podskupini (aripiprazol, n = 69; placebo, n = 36) od 0,242 do 0,879, tako da je pri starejših bolnikih mogoče sprejeti zaključek o učinkovitosti zdravljenja.
These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or preoccupation with an increase in sexual thoughts or feelings.
To se imenuje motnja nadzora impulzov, kamor štejemo vedenja, kot so odvisnost od hazardiranja, čezmerno uživanje hrane ali trošenje denarja, nenormalno povečan libido ali preokupacija z mislimi na spolnost ali spolnimi občutki.
Therefore, Aripiprazole Zentiva is not recommended for use in patients below 13 years of age (see sections 4.8 and 5.1).
Uporabe zdravila Aripiprazol Zentiva se zato pri bolnikih, mlajših od 13 let, ne priporoča (glejte poglavji 4.8 in 5.1).
However, the concentrations of the sulphate conjugates of hydroxy aripiprazole in human bile at the highest dose proposed, 30 mg per day, were no more than 6% of the bile concentrations found in the monkeys in the 39-week study and are well below (6%) their limits of in vitro solubility.
Vendar je bila koncentracija sulfatnih konjugatov hidroksiaripiprazola v človeškem žolču v 39-tedenski raziskavi ob največjem priporočenem odmerku 30 mg na dan le 6 % koncentracije v žolču pri opicah ter je bila bistveno pod mejo (6 %) njihove topnosti in vitro.
In three placebo-controlled trials (n = 938; mean age: 82.4 years; range: 56 - 99 years) of aripiprazole in elderly patients with psychosis associated with Alzheimer's disease, patients treated with aripiprazole were at increased risk of death compared to placebo.
V treh s placebom nadzorovanih preskušanjih (n = 938, povprečna starost: 82,4 leta, razpon: 5699 let) aripiprazola pri starejših bolnikih s psihozo, povezano z Alzheimerjevo boleznijo, je bilo tveganje smrti večje pri bolnikih, ki so dobivali aripiprazol, kot pri tistih, ki so dobivali placebo.
The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known:
O naslednjih neželenih učinkih so poročali v obdobju od prihoda zdravila aripiprazol v peroralni obliki na trg; pogostnost pojavljanja le-teh pa ni znana:
• Triptans (such as sumatriptan and zolmitripitan) used for treating migraine
• triptane (kot sta sumatriptan in zolmitriptan) uporabljamo za zdravljenje migrene.
The safety profile in a 26-week open-label extension trial was similar to that observed in the shortterm, placebo-controlled trial.
V 26-tedenskem, odprtem, podaljšanem preskušanju je bil profil varnosti podoben profilu varnosti v kratkotrajnem, s placebom nadzorovanem preskušanju.
Actual scores in rating scales used as secondary endpoints, including PANSS and the Montgomery-Asberg Depression Rating Scale showed a significant improvement over haloperidol.
Dejanske ocene po ocenjevalnih lestvicah (vključno s PANSS in lestvico Montgomery-Asberg Depression Rating Scale), ki so predstavljale sekundarne končne točke, so pokazale značilno izboljšanje v primerjavi s haloperidolom.
Potential for aripiprazole to affect other medicinal products In clinical studies, 10 - 30 mg/day doses of aripiprazole had no significant effect on the metabolism of substrates of CYP2D6 (dextromethorphan/3-methoxymorphinan ratio), CYP2C9 (warfarin), CYP2C19 (omeprazole), and CYP3A4 (dextromethorphan).
V kliničnih študijah odmerki od 10 do 30 mg aripiprazola na dan niso pomembno vplivali na presnovo substratov CYP2D6 (razmerje dekstrometorfan/3-metoksimorfinan), CYP2C9 (varfarin), CYP2C19 (omeprazol) ali CYP3A4 (dekstrometorfan).
Aripiprazole Zentiva is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
Zdravilo Aripiprazol Zentiva je indicirano za zdravljenje shizofrenije pri odraslih in mladostnikih, starih 15 let in več.
It is important that you carry on taking Aripiprazole Zentiva for as long as your doctor has told you to.
Pomembno je, da zdravljenje z zdravilom Aripiprazol Zentiva nadaljujete tako dolgo, kot vam je svetoval zdravnik.
The safety and efficacy of aripiprazole in children and adolescents aged below 18 years have not yet been established.
Varnost in učinkovitost aripiprazola pri otrocih in mladostnikih, mlajših od 18 let, še nista bili dokazani.
In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (quinidine) increased aripiprazole AUC by 107%, while Cmax was unchanged.
V kliničnem preskušanju pri zdravih preiskovancih je močan zaviralec CYP2D6 (kinidin) zvečal AUC aripiprazola za 107 %, Cmax pa se ni spremenila.
• Muscle stiffness, and drowsiness or sleepiness, slower breathing, choking, high or low blood pressure, abnormal rhythms of the heart.
• okorelost mišic in omotičnost ali zaspanost, upočasnjeno dihanje, dušenje, visok ali nizek krvni tlak, motnje srčnega ritma.
Tics associated with Tourette's disorder
Trzaji, povezani s Tourettovim sindromom
The rate of death in aripiprazoletreated patients was 3.5% compared to 1.7% in the placebo group.
Delež smrti je bil v skupini z aripiprazolom 3,5 % in v skupini s placebom 1,7 %.
Extrapyramidal symptoms were mainly reported during the stabilisation phase in 17% of patients, with tremor accounting for 6.5%.
O ekstrapiramidnih simptomih so poročali predvsem med stabilizacijsko fazo, in sicer pri 17 % bolnikov, od tega je 6,5 %
• in blood tests: increased or fluctuating blood sugar, increased glycosylated haemoglobin.
• krvne preiskave: povišanje ali nihanje ravni sladkorja v krvi, zvišana raven glikoziliranega hemoglobina,
What you need to know before you take Aripiprazole Zentiva Do not take Aripiprazole Zentiva
Kaj morate vedeti, preden boste vzeli zdravilo Aripiprazol Zentiva Ne jemljite zdravila Aripiprazol Zentiva
Class effect - Symptoms of dystonia, prolonged abnormal contractions of muscle groups, may occur in susceptible individuals during the first few days of treatment.
Učinek zdravil iz te skupine (“Class Effect”) - V prvih nekaj dneh zdravljenja se lahko pri dovzetnih posameznikih pojavijo simptomi distonije, podaljšane nenormalne kontrakcije mišičnih skupin.
In a 60- to 89-week, randomised, double-blind, placebo-controlled trial in adolescent subjects (n = 146; ages 13 - 17 years) with schizophrenia, there was a statistically significant difference in the rate of relapse of psychotic symptoms between the aripiprazole (19.39%) and placebo (37.50%) groups.
V 60- do 89-tedenskem, randomiziranem, dvojnoslepem, s placebom kontroliranem preskušanju pri mladostnikih s shizofrenijo (n = 146; v starosti od 13 do 17 let) je bilo opaziti statistično značilno razliko v stopnji ponovitve psihotičnih simptomov med skupinama bolnikov, zdravljenih z aripiprazolom (19,39 %) in s placebom (37,50 %).
What Aripiprazole Zentiva is and what it is used for
Kaj je zdravilo Aripiprazol Zentiva in za kaj ga uporabljamo
Orodispersible tablets may be used as an alternative to Aripiprazole Zentiva tablets for patients who have difficulty swallowing Aripiprazole Zentiva tablets (see section 5.2).
Orodisperzibilne tablete se lahko uporabijo kot alternativa tabletam Aripiprazol Zentiva pri bolnikih, ki tablete Aripiprazol Zentiva težko pogoltnejo (glejte poglavje 5.2).
The Kaplan-Meier rates for recurrence to any mood episode for the adjunctive treatment arm were 16% in aripiprazole + lithium and 18% in aripiprazole + valproate compared to 45% in placebo + lithium and 19% in placebo + valproate.
Po Kaplan-Meierjevi metodi izračunani deleži ponovitev katerekoli razpoloženjske epizode pri uporabi dodatnega zdravila so bili 16 % pri uporabi kombinacije aripiprazol + litij in 18 % pri uporabi kombinacije aripiprazol + valproat v primerjavi s 45 % pri kombinaciji placebo + litij ter 19 % pri kombinaciji placebo + valproat.